Samandhy Cedeño Briceño
Técnico/a sénior de laboratorio
Grupo de investigación
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.
Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PLWH with poor immune reconstitution.
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells.
Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients.